Who Pays the Price? Overdraft Fee Ceilings and the Unbanked

Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?

Implantable cardioverter defibrillators (ICDs) are an established therapy for the prevention of sudden cardiac death. Since the 1990s multiple primary and secondary prevention trials, such as AVID, MADIT-I and II and SCD-HeFT, have demonstrated a significant reduction in mortality in patients with ischaemic and non-ischaemic cardiomyopathy, especially in survivors of ventricular arrhythmias cau...

Healthcare and Insurance: Who Pays the Piper?

The costs of caring: Who pays? Who profits? Who panders?

Avastin, a widely used colon cancer drug manufactured by San Francisco-based biotech company Genentech, has proven a somewhat effective treatment for lung and breast cancer when administered at twice the normal dose. In February, the New York Times carried a story about Avastin's extraordinarily high price when used in this alternative way: $100,000 for one year's treatment--a figure fully twic...

Who pays the price for high neuroticism? Moderators of longitudinal risks for depression and anxiety.

BACKGROUND High neuroticism is a well-established risk for present and future depression and anxiety, as well as an emerging target for treatment and prevention. The current analyses tested the hypothesis that physical, social and socio-economic disadvantages each amplify risks from high neuroticism for longitudinal increases in depression and anxiety symptoms. METHOD A national sample of adu...

Medicare reform: who pays and who benefits?

As Medicare's share of federal spending and gross domestic product (GDP) rises, the program may have increasingly important consequences not only for the health of Americans but also for their net income and financial well-being. We use incidence analysis to study payments and benefits in Medicare to various generations and income groups. We find that Medicare actually provides larger net dolla...